DR. JAMES YU CHANG SHEN M.D. NPI 1063792265

NPI Information

  • NPI: 1063792265
  • Provider Name: DR. JAMES YU CHANG SHEN, M.D.
  • Classification: Internal Medicine - 207RH0003X
  • Specialization: Hematology & Oncology
  • Entity Type: Individual
  • PECOS Registration: Yes
  • Address: 301 W HUNTINGTON DR
    ARCADIA, CA
    ZIP 91007
  • Phone: (626) 218-9840

Map and Directions

Get Directions

NPI Details

DR. James Yu Chang Shen, M.D. is a hematology and oncology internal medicine in Arcadia, CA with 15 years of experience. The provider is an internist doctor of osteopathy that specializes in the treatment of the combination of hematology and oncology disorders. A doctor of osteopathy that is board eligible/certified by the American Osteopathic Board of Internal Medicine WAS able to obtain a Certificate of Special Qualifications in the field of Hematology and Oncology. The Certificate is NO longer offered. DR. James Yu Chang Shen, M.D. NPI is 1063792265. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE
Graduation Year:2010

The provider's business location address is:

301 W HUNTINGTON DR
ARCADIA, CA
ZIP 91007-462
Phone: (626) 218-9840
Fax: (626) 218-9860

The NPI 1063792265 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

  • Injection, darbepoetin alfa, 1 microgram (non-esrd use) (HCPCS:J0881)
  • Injection, aprepitant, 1 mg (HCPCS:J0185)
  • Injection, oxaliplatin, 0.5 mg (HCPCS:J9263)
  • Injection, denosumab, 1 mg (HCPCS:J0897)
  • Injection, pembrolizumab, 1 mg (HCPCS:J9271)
  • Injection, paclitaxel, 1 mg (HCPCS:J9267)
  • Injection, ondansetron hydrochloride, per 1 mg (HCPCS:J2405)
  • Injection, bevacizumab-awwb, biosimilar, (mvasi), 10 mg (HCPCS:Q5107)
  • Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
  • Injection, leucovorin calcium, per 50 mg (HCPCS:J0640)
  • Injection, fluorouracil, 500 mg (HCPCS:J9190)
  • Injection, pegfilgrastim, excludes biosimilar, 0.5 mg (HCPCS:J2506)
  • Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
  • Injection of additional new drug or substance into vein (HCPCS:96375)
  • Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
  • Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
  • Follow-up hospital inpatient care per day, typically 35 minutes (HCPCS:99233)
  • Injection of drug or substance under skin or into muscle (HCPCS:96372)
  • Injection, carboplatin, 50 mg (HCPCS:J9045)
  • Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
  • Leuprolide acetate (for depot suspension), 7.5 mg (HCPCS:J9217)
  • Infusion into a vein for hydration, each additional hour (HCPCS:96361)
  • Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
  • Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
  • Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l (HCPCS:G0498)
  • Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
  • Collection of blood sample from implanted device (HCPCS:36591)
  • Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
  • Unclassified drugs (HCPCS:J3490)
  • Infusion into a vein for hydration, 31-60 minutes (HCPCS:96360)
  • Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion (HCPCS:96368)
  • New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
  • Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
  • Administration of additional new drug or substance into vein using push technique (HCPCS:96411)
  • Infusion, normal saline solution , 1000 cc (HCPCS:J7030)
  • Telephone medical discussion with physician, 11-20 minutes (HCPCS:99442)
  • Initial hospital inpatient care per day, typically 50 minutes (HCPCS:99222)
  • Infusion, normal saline solution, sterile (500 ml = 1 unit) (HCPCS:J7040)
  • Irrigation of implanted venous access drug delivery device (HCPCS:96523)
  • Advance care planning, first 30 minutes (HCPCS:99497)
  • Injection of drug or substance into vein (HCPCS:96374)
  • New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
  • Initial hospital inpatient care per day, typically 70 minutes (HCPCS:99223)
  • Initial hospital inpatient care per day, typically 30 minutes (HCPCS:99221)
  • Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)

The enumeration date for this NPI number is 8/19/2011 and was last updated on 11/11/2020.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

No. Taxonomy Code Taxonomy Clasification Taxonomy Specialization License Number License State Primary
1207RH0003XInternal MedicineHematology & OncologyA124341CALIFORNIAYes
2207RX0202XInternal MedicineMedical OncologyA124341CALIFORNIANo

What is NPI?

NPI stands for National Provider Identifier. The NPI is a 10-digit identification number that is completely unique. The NPI number by itself does not contain any identifiable information such as a provider’s speciality or location. The NPI is assigned to individuals or organizacions for their lifespan and it is independent of key provider information type updates like a change of practices, location or speciality.

This page was last updated on: 3/30/2025

NPI Synchronization or Removal

All materials and services on this site are provided on an "as is" and "as available" basis without warranty of any kind. The NPI record is maintained by the National Plan & Provider Enumeration System (NPPES) and anyone may request this information and other NPPES health care provider data from HHS under The Freedom of Information Act (FOIA), Title 5 of the United States Code, section 552. To update the NPI records please contact the NPPES.